Urinary incontinence rates in salvage high-dose-rate brachytherapy prostate cancer patients

被引：0
|
作者：
Wojcieszek, P. [1 ,2 ]
Szlag, M. [1 ,2 ]
Cholewka, A. [1 ,2 ]
Bialas, B. [1 ,2 ]
Kellas-Sleczka, S. [1 ,2 ]
Fijalkowski, M. [1 ,2 ]
Andrejczuk, A. [1 ,2 ]
机构：
[1] Maria Sklodowska Curie Mem Canc Ctr, Gliwice, Poland
[2] Inst Oncol III Dept, Brachytherapy Dept, Gliwice, Poland
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 119卷
关键词：
D O I：
10.1016/S0167-8140(16)31288-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PV-0039
引用
收藏
页码：S16 / S16
页数：1
相关论文
共 50 条
  • [21] Clinical outcomes of focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer.
    Peters, M.
    Van Son, M. J.
    Moerland, M. A.
    Lagendijk, J. J. W.
    van Zyp, J. R. N. Van der Voort
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S141 - S142
  • [22] High-Dose-Rate Brachytherapy in the Curative Treatment of Patients With Localized Prostate Cancer
    Pisansky, Thomas M.
    Gold, Douglas G.
    Furutani, Keith M.
    Macdonald, O. Kenneth
    McLaren, Robert H.
    Mynderse, Lance A.
    Wilson, Torrence M.
    Hebl, James R.
    Choo, Richard
    MAYO CLINIC PROCEEDINGS, 2008, 83 (12) : 1364 - 1372
  • [23] Implementation of High-Dose-Rate Brachytherapy and Androgen Deprivation in Patients With Prostate Cancer
    Lilleby, Wolfgang
    Tafjord, Gunnar
    Raabe, Nils K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (03): : 933 - 939
  • [24] The emerging role of high-dose-rate brachytherapy for prostate cancer
    Morton, GC
    CLINICAL ONCOLOGY, 2005, 17 (04) : 219 - 227
  • [25] Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients
    van Son, Marieke
    Peters, Max
    Moerland, Marinus
    van de Pol, Sandrine
    Eppinga, Wietse
    Lagendijk, Jan
    van Zyp, Jochem van der Voort
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 27 : 1 - 7
  • [26] High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy
    Chatzikonstantinou, Georgios
    Zamboglou, Nikolaos
    Roedel, Claus
    Zoga, Eleni
    Strouthos, Iosif
    Butt, Saeed Ahmed
    Tselis, Nikolaos
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (09) : 683 - 691
  • [27] Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after primary radiotherapy failure
    Wojcieszek, Piotr
    Szlag, Marta
    Glowacki, Grzegorz
    Cholewka, Agnieszka
    Gawkowska-Suwinska, Marzena
    Kellas-Sleczka, Sylwia
    Bialas, Brygida
    Fijalkowski, Marek
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 (03) : 405 - 410
  • [28] Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results
    Jo, Yoshimasa
    Fujii, Tomohiro
    Hara, Ryoei
    Yokoyama, Teruhiko
    Miyaji, Yoshiyuki
    Yoden, Eisaku
    Hiratsuka, Junichi
    Nagai, Atsushi
    BJU INTERNATIONAL, 2012, 109 (06) : 835 - 839
  • [29] High-dose-rate brachytherapy as a salvage treatment for locally recurrent prostate cancer after primary radiotherapy
    Tharmalingam, Hannah
    Hamada, Mayumi
    Tsang, Yatman
    Hoskin, Peter
    Alonzi, Roberto
    CLINICAL ONCOLOGY, 2018, 30 : E4 - E5
  • [30] High-dose-rate brachytherapy as a salvage treatment for locally recurrent prostate cancer after primary radiotherapy
    Tharmalingam, Hannah
    Hamada, Mayumi
    Tsang, Yatman
    Hoskin, Peter
    Alonzi, Roberto
    CLINICAL ONCOLOGY, 2018, 30 : E1 - E2
12345